Zhuo, Zhili
Lu, Wenping
Zhang, Ling
Zhang, Dongni
Cui, Yongjia
Wu, Xiaoqing
Mei, Heting
Chang, Lei
Song, Qingya
Funding for this research was provided by:
High Level Chinese Medical Hospital Promotion Project - Special Project on Formulation R&D and New Drug Translation for Medical Institutions (HLCMHPP2023037)
State Administration of Traditional Chinese Medicine (ZYZB-2022-798)
Article History
Received: 3 April 2024
Accepted: 11 November 2024
First Online: 18 December 2024
Declarations
:
: This study was approved by the Ethics Committee of Guang’anmen Hospital, China Academy of Chinese Medical Sciences, ethics approval number 2022-179-KY. This protocol was reviewed and approved by the Ethics Committee of Guang’anmen Hospital, China Academy of Chinese Medical Sciences, in accordance with the ethical guidelines of the World Medical Association’s Declaration of Helsinki (2013), the Council for International Organizations of Medical Sciences (CIOMS), and the World Health Organization (WHO) International Ethical Guidelines for Health-Related Research Involving Humans. Informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.